This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
IVERMECTINE
COVID-19
Ivermectin : enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations
The mechanisms of action of Ivermectin against SARS-CoV-2
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
Ivermectin for Prevention and Treatment of COVID-19 Infection
Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID- 19 Mortality Rate in a Dose-Response Manner
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations
Tolérance de l’ivermectine orale chez l’enfant
CANCER
Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
A review of Ivermectin use in cancer patients
Actions of Ivermectin on Cancer
Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Outcome of Ivermectin in Cancer Treatment : An Experience in Loja-Ecuador
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells